Matthew J Kipper

Title: Innovations by Matthew J Kipper

Introduction

Matthew J Kipper is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunogenic formulations, holding a total of 2 patents. His work focuses on developing controlled-release systems that enhance immune responses, particularly in vaccine formulations.

Latest Patents

Kipper's latest patents include innovative controlled-release immunogenic formulations designed to modulate immune responses. These formulations utilize single-dose controlled-release systems based on bioerodible polyanhydride copolymer or homopolymer microparticles. The unique design allows for the degradation of these microparticles through surface-erosion, resulting in a controlled release of immunogen(s) to patients. This advancement has the potential to improve vaccine efficacy and patient outcomes.

Career Highlights

Matthew J Kipper is affiliated with the Iowa State University Research Foundation Inc., where he continues to push the boundaries of immunology and vaccine development. His research has garnered attention for its innovative approach to enhancing immune responses through controlled-release mechanisms.

Collaborations

Kipper has collaborated with notable colleagues, including Michael J Wannemuehler and Balaji Narasimhan. These partnerships have contributed to the advancement of his research and the development of new technologies in the field.

Conclusion

Matthew J Kipper's work in controlled-release immunogenic formulations represents a significant advancement in vaccine technology. His contributions are poised to make a lasting impact on the field of immunology and public health.